Cargando…
Priming with a gonadotropin-releasing hormone agonist before immature oocyte retrieval may improve maturity of oocytes and outcome in in vitro maturation (IVM) cycle: a case report
BACKGROUND: The concept of using a gonadotropin-releasing hormone agonist (GnRH-a) instead of human chorionic gonadotropin for triggering ovulation in patients treated with an antagonist protocol for in vitro fertilization (IVF) has become a routine clinical practice. It may promote oocyte nuclear m...
Autores principales: | Smirnova, A., Anshina, M., Paz, E. Shalom, Ellenbogen, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004412/ https://www.ncbi.nlm.nih.gov/pubmed/33771223 http://dx.doi.org/10.1186/s13256-021-02706-8 |
Ejemplares similares
-
In vitro maturation (IVM) of human immature oocytes: is it still relevant?
por: Das, Mausumi, et al.
Publicado: (2023) -
Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte
por: Yang, Huixia, et al.
Publicado: (2021) -
A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles†
por: Son, Weon-Young, et al.
Publicado: (2008) -
The Effect of the Duration of In Vitro Maturation (IVM) on Parthenogenetic Development of Ovine Oocytes
por: Shirazi, Abolfazl, et al.
Publicado: (2009) -
IVM of human immature oocytes for infertility treatment and fertility preservation
por: Chian, Ri‐Cheng, et al.
Publicado: (2023)